English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Federal tax deduction changes linked to local school funding decisions, researchers say
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Study finds genetic changes in schistosomiasis parasite may signal emerging drug resistance
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Eli Lilly announces $3.8 billion acquisition of AtaiBeckley in psychedelics sector
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Experts discuss emerging alternatives to opioids for pain relief
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Blood-based gene tests may aid early detection of pancreatic cancer, researchers say
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Medicaroid receives CE marking for hinotori surgical robot system
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Braveheart, Attovia and Vogenx announce IPO plans amid surge in biotech listings
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Review highlights ZBP1 as potential target to overcome cancer immunotherapy resistance

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes